Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphomas: Non-Hodgkin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03816683
What this trial is testing

A Disease Registry of Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
AstraZeneca 227
Not applicableLooking for participantsNCT03280394
What this trial is testing

Liquid Biopsy in Mature B-cell Tumors

Who this might be right for
Mature B-Cell Neoplasm
Oncology Institute of Southern Switzerland 444
Not applicableEnded earlyNCT06382194
What this trial is testing

Decision Making Tool for Firearm Storage

Who this might be right for
Dementia, MildDepression
University of Washington 5
Not applicableLooking for participantsNCT06710418
What this trial is testing

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more
University of Washington 50
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Not applicableStudy completedNCT07103486
What this trial is testing

Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 264
Early research (Phase 1)Study completedNCT02809573
What this trial is testing

Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Chipscreen Biosciences, Ltd. 30
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)UnknownNCT05453669
What this trial is testing

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)Study completedNCT00787969
What this trial is testing

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 74
Early research (Phase 1)WithdrawnNCT04052061
What this trial is testing

QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaLarge-cell LymphomaLymphoma, B-Cell+1 more
ImmunityBio, Inc.
Early research (Phase 1)Ended earlyNCT02931110
What this trial is testing

Study of IV CBL0137 in Previously Treated Hematological Subjects

Who this might be right for
Hematological Malignancies
Incuron 5
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Early research (Phase 1)Study completedNCT02741388
What this trial is testing

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP

Who this might be right for
B-cell Lymphoma
The Lymphoma Academic Research Organisation 39
Early research (Phase 1)Study completedNCT00274742
What this trial is testing

Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHL

Who this might be right for
Non-Hodgkin's Lymphoma, Relapsed
Amgen Research (Munich) GmbH 76
Early research (Phase 1)Study completedNCT00864942
What this trial is testing

Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
Georgetown University 28
Early research (Phase 1)Study completedNCT00614042
What this trial is testing

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL)
Aptevo Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT03097770
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Next Page